This study used a cost-minimization analysis (CMA) to determine whether and to what extent student pharmacists’ interventions reduce out-of-pocket PDP costs for Medicare beneficiaries.
Survival analysis of pyrotinib in HER2-positive metastatic breast cancer: A multicenter real-world study. A randomized, double-blind, three-arm, parallel group, phase 1 study to assess the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results